The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques
Ronan Depoortère, Tom H. Johnston, Susan H. Fox, Jonathan M. Brotchie, Adrian Newman‐Tancredi
Topics & Concepts
AgonistMPTPPharmacology5-HT1A receptorChemistryPartial agonistFunctional selectivityReceptorMedicine5-HT receptorInternal medicineSerotoninParkinson's diseaseDiseaseNeurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and TreatmentsNicotinic Acetylcholine Receptors Study